Barrientos, Anna Marie .

HRN: 27-86-31  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2025
AMPICILLIN 1GM (VIAL)
09/26/2025
09/27/2025
IV
2g
Q6hr
Thinly MSAF
Checking Initial Appropriateness 
09/26/2025
CEFUROXIME 1.5GM (VIAL)
09/26/2025
09/27/2025
IV
1.5gms
Q8hrs X 3 Doses
S/P Primary LSTCS With IUD
Checking Initial Appropriateness 
09/26/2025
CEFUROXIME 500MG (TAB)
09/26/2025
10/03/2025
PO
500mg
BID X 7 Days
S/P Primary LSTCS With IUD
Checking Initial Appropriateness 
09/26/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/26/2025
09/27/2025
IV
500mg
Q8hrs X 3 Doses
S/P Primary LSTCS With IUD
Checking Initial Appropriateness 
09/26/2025
METRONIDAZOLE 500MG (TAB)
09/26/2025
10/03/2025
PO
500mg
TID X 7 Days
S/P Primary LSTCS With IUD
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: